X0609 4 2026-10-22 0002012593 Rapport Therapeutics, Inc. RAPP 0001237564 PAUL STEVEN M false RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100 BOSTON MA 02110 true false false false false Common Stock 2026-10-22 4 P false 35714 27.28 A 77380 I By Paul Capital Strategy III Fund LLC Common Stock 477642 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.87 to $27.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. /s/ Troy Ignelzi, Attorney-in-Fact 2026-10-22